CompletedPhase 1NCT00873782
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
Studying Becker muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- William J. Powers, MD, MDUniversity of North Carolina
- Intervention
- Retrograde high pressure transvenous perfusion with normal saline(other)
- Enrollment
- 16 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2009 – 2014
Study locations (1)
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · University of North Carolina
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00873782 on ClinicalTrials.govOther trials for Becker muscular dystrophy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07565272Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals With Duchenne Muscular DystrophyIstanbul University
- ENROLLING BY INVITATIONNANCT07543302Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?taVNS AB
- RECRUITINGNCT07515235DMD Gene Variants and Cardiac Dysfunction in Young Males With DystrophinopathiesAristotle University Of Thessaloniki
- RECRUITINGNANCT07415421Parathyroidectomy After Kidney TransplantationAarhus University Hospital
- ACTIVE NOT RECRUITINGNCT07519720An Assessment of Risk Factors for Osteosarcopenia in Older Adults - the Role of Prevention, Lifestyle, Physical Activity and Education.Wroclaw University of Health and Sport Sciences
- ENROLLING BY INVITATIONPHASE1NCT07178327Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101Shanghai TTM-Bio Technology Co., Ltd
- RECRUITINGNCT07565051Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?University Hospital, Geneva
- RECRUITINGNANCT06949280Metabolic Health, Bones and Nuts During Weight Loss in AdultsRutgers, The State University of New Jersey